This content is machine translated Skin cancer Do we need to rethink our lifestyle in the fight against skin cancer? The topic could hardly be more explosive: Already about half of the over 60-year-olds suffer from actinic tumors. In Switzerland, we are also European champions in terms of melanoma incidence.…
View Post 6 min This content is machine translated Actinic keratosis Early treatment is indicated Actinic or solar keratoses represent in situ squamous cell carcinomas of the skin and are one of the more common dermatoses in daily practice. On the one hand, it is…
View Post 2 min This content is machine translated German-speaking European School of Oncology in St. Gallen The pros and cons of antiangiogenic therapy in first-line treatment. At a DESO advanced training course in St. Gallen, Prof. Volker Heinemann, MD, Munich, and Prof. Werner Scheithauer, MD, Vienna, led a discussion on the use of first-line antiangiogenic therapies.…
View Post 8 min This content is machine translated Advanced training Hautnah Guidelines – what to consider for diagnostics? In malignant melanoma, some new findings on prognostic factors and risks have been published recently. The changed guidelines bring some innovations in everyday life and aim at a most accurate…
View Post 10 min This content is machine translated Skin surgery Tips and tricks for practice The majority of simple surgical procedures on the skin organ can be easily performed in the office. However, as with any surgical procedure, a clear indication and selection of the…
View Post 4 min This content is machine translated Breast Cancer How should action be taken without accurate study results? What is the evidence for primary tumor and metastasis in breast carcinoma? Are there treatment options that will not harm the child if a pregnant woman is found to have…
View Post 8 min This content is machine translated New therapies Progress in metastatic malignant melanoma New insights in tumor biology and immunology as well as in molecular pathology have rapidly driven the development of immunomodulatory antibodies and so-called “targeted” therapeutics [1]. This makes the therapy…
View Post 4 min This content is machine translated 5th SSHO in St. Gallen How do advances in treatment translate to clinical practice? Several studies in the area of chronic lymphocytic leukemia have attracted attention in recent years, most notably, of course, the CLL11 study, which demonstrated a clear benefit of the combination…
View Post 2 min This content is machine translated SAKK publication Cancer patients receive different regional treatment at the end of their lives A study co-led by the Swiss Association for Clinical Cancer Research (SAKK) and published in the journal BMC Cancer concludes that place of residence, insurance, age, and type of cancer…
View Post 12 min This content is machine translated Neuroendocrine tumors Not as rare as you might think Neuroendocrine tumors (NET) are not that rare. The prevalence of these tumors in the gastrointestinal tract is exceeded only by colon carcinoma. Often NETs are not detected until the late…
View Post 5 min This content is machine translated Geriatrics Oncology treatment for seniors: a luxury? The risk of developing cancer increases steadily over the course of a lifetime. Thus, 60% of new cancer cases occur after the age of 65 and approximately 60 to 70%…
